IInvivo Partners
Invivo Partners is a Barcelona-based venture capital firm that invests early in companies working at the intersection of biotechnology and AI-driven deeptech. It backs European companies, with a focus on Spain, from pre-seed to Series A. Its biotech investments centre on new drugs, especially advanced therapies and synthetic biology. Initial tickets are €2–4M, with follow-ons of up to €10M per company. Its funds include Healthequity (2012), Invivo Ventures (2019, €60M final close), Invivo Ventures III (2023, €100M target) and Invivo Ventures AI (2025, €100M target). The portfolio includes Minoryx Therapeutics, Peptomyc, ARTHEx Biotech, Integra Therapeutics and Corteria Pharmaceuticals, and its exits include Sanifit (acquired by Vifor Pharma), Versantis (acquired by Genfit) and EsoBiotec.
Team
Portfolio companies 8
Open 8 as list → On map →
T
A
G
I
O
T
E